Christian Weyer

Evp, Research & Development at Intercept Pharmaceuticals Inc. (ICPT), 2021-04-05
See Remarks at Fate Therapeutics Inc (FATE), 2015-04-14
Svp, Research & Development at Amylin Pharmaceuticals Inc (AMLN), 2012-08-10

Insider Trading: Sales See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Intercept Pharmaceuticals Inc.	ICPT	$85.95	181	Officer	17,140	2020-04-27	Filing
Intercept Pharmaceuticals Inc.	ICPT	$87.62	113	Officer	17,367	2020-02-27	Filing
Intercept Pharmaceuticals Inc.	ICPT	$94.04	723	Officer	17,837	2020-01-27	Filing
Intercept Pharmaceuticals Inc.	ICPT	$123.24	1,581	Officer	14,178	2019-12-27	Filing
Intercept Pharmaceuticals Inc.	ICPT	$101.65	1,040	Officer	15,646	2019-11-27	Filing